U.S. Markets closed

Krystal Biotech, Inc. (KRYS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
65.05-0.42 (-0.64%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 387.29
52 Week Low 337.68
50-Day Moving Average 368.91
200-Day Moving Average 368.94

Share Statistics

Avg Vol (3 month) 397.85k
Avg Vol (10 day) 377.24k
Shares Outstanding 522.2M
Implied Shares Outstanding 6N/A
Float 15.29M
% Held by Insiders 124.77%
% Held by Institutions 164.36%
Shares Short (Apr 14, 2021) 41.2M
Short Ratio (Apr 14, 2021) 410.6
Short % of Float (Apr 14, 2021) 46.82%
Short % of Shares Outstanding (Apr 14, 2021) 45.42%
Shares Short (prior month Mar 14, 2021) 41.16M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-7.93%
Return on Equity (ttm)-13.00%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.15M
Net Income Avi to Common (ttm)-32.17M
Diluted EPS (ttm)-1.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)271.26M
Total Cash Per Share (mrq)12.22
Total Debt (mrq)3.95M
Total Debt/Equity (mrq)1.35
Current Ratio (mrq)17.80
Book Value Per Share (mrq)14.82

Cash Flow Statement

Operating Cash Flow (ttm)-26.08M
Levered Free Cash Flow (ttm)-19.98M